Dermata Therapeutics, Inc. — 8-K Filings
72 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Dermata Therapeutics, Inc. (DRMAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Dermata Therapeutics, Inc. has filed 72 8-K documents with the SEC since 2021. To view all SEC filings by Dermata Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001654954-23-001927 | Feb 21, 2023 | — |
| 8-K | FORM 8-K | 0001654954-23-001476 | Feb 8, 2023 | — |
| 8-K | FORM 8-K | 0001654954-22-016569 | Dec 15, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-016099 | Dec 5, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-015036 | Nov 10, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-012918 | Sep 23, 2022 | Sep 21, 2022 |
| 8-K | FORM 8-K | 0001654954-22-011373 | Aug 15, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-009535 | Jul 11, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-008770 | Jun 24, 2022 | Jun 21, 2022 |
| 8-K | FORM 8-K | 0001654954-22-008628 | Jun 22, 2022 | Jun 17, 2022 |
| 8-K | FORM 8-K | 0001654954-22-007063 | May 17, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-006969 | May 16, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-005375 | Apr 25, 2022 | Apr 20, 2022 |
| 8-K | FORM 8-K | 0001654954-22-003871 | Mar 28, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-002423 | Mar 2, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-001134 | Feb 4, 2022 | — |
| 8-K | CURRENT REPORT | 0001654954-22-000428 | Jan 13, 2022 | Jan 12, 2022 |
| 8-K | FORM 8-K | 0001654954-21-013038 | Dec 10, 2021 | Dec 6, 2021 |
| 8-K | CURRENT REPORT | 0001654954-21-012446 | Nov 19, 2021 | — |
| 8-K | FORM 8-K | 0001654954-21-012224 | Nov 15, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-010436 | Sep 27, 2021 | — |
| 8-K | 8-K | 0001193125-21-263316 | Sep 1, 2021 | — |